Indicators

Markets:

News

Latest News about MYCOF

Recent news which mentions MYCOF

Global Psychedelic Drugs Market Expected To Reach $10.2B By 2028 Amid Growing Mental Health Crises

October 28, 2024

EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves

July 31, 2024

Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More

February 15, 2024

Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More

October 16, 2023

Psychedelic-Based Drugs Biotech Company Begins Trading On UK's AQSE Growth Market

October 12, 2023

Psyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly Reports

August 21, 2023

Mydecine Releases Q2 2023: Developer Of Smoke Cessation Psilocybin Prodrugs & MDMA Analogs

August 15, 2023

Jamaica Launches Organic Psilocybin Gummies & New Psychedelic Retreat: Rose Hill's New Offer

August 01, 2023

Mydecine's Prospectus Supplement Closing Under Share Subscription And Management Update

May 30, 2023

Psyched: New Psilocybin Forms, LSD Anxiety Study, UK's Parliamentary Debate And More

May 23, 2023

Mydecine's Q1 2023 Reports Shows Decline In Assets And R&D, Increase In Net Loss And Accumulated Deficit

May 17, 2023

Psyched: Oregon And Colorado Regulations, MindMed CEO Discusses LSD Therapy, Mia Khalifa Enters Market & More

May 01, 2023

New Set Of MDMA Analogs To Hit The Clinic: These Are The Latest Positive Findings

April 25, 2023

Mydecine: 2022 Financials & Business Update By Next-Gen Psychedelics Producer, Smoke Cessation Trial And More

April 03, 2023

What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways

January 03, 2023

Psyched: First Ayahuasca Pill Created, Psychedelics Legalization Predicted, UK's Research Support And More

December 19, 2022

Psychedelic Company Sale: Mydecine Gets Over $2.5M For Wholly-Owned Tech Subsidiary Business

December 13, 2022

Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More

November 21, 2022

Mydecine's Q3 Financials & Update, Sustained Target On Smoking Cessation For Next 12 Months

November 15, 2022

Psychedelics Biotechs Clearmind And Mydecine Share Consolidation And Subscription Agreements

September 26, 2022

World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them

August 30, 2022

Mydecine Innovations Group Reports Q2 Financial Results And Management Updates

August 16, 2022

Two Psychedelic Companies File Patent Applications For Psilocybin And MDMA Analogues, Here's What Could Change

July 19, 2022

Government-Funded Smoking Cessation Trial Uses Mydecine's New Psilocybin-Derived MYCO-001, Recently FDA-Approved

June 17, 2022

Mydecine Announces 1-for-50 Reverse Stock Split

April 14, 2022

Psyched: Atai, MindMed, Enveric and Mydecine Release 2021 Earnings, Bienstar Expands To Brazil & More!

April 06, 2022

Mydecine Reports Financial Results For 2021

April 01, 2022

Benzinga's Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th

February 09, 2022

Mind Medicine to Study Effect of Time on LSD Microdosing

December 17, 2021

Mydecine: Q3 Financials, Advances Research On Psychedelic Therapies For Mental Health & Addiction Disorders

November 16, 2021

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.